A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease

Author： Poturoglu Sule   Kaymakoglu Sabahattin   Gurel Polat Nuray   Ibrisim Duygu   Ahishali Emel   Akyuz Filiz   Badur Selim   Demir Kadir   Mungan Zeynel  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.69, Iss.6, 2009-10, pp. : 696-702

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologic dose tailoring in Crohn disease

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 2, 2015-02 ,pp. : 170-177

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin‐10 and tumour necrosis factor‐alpha serum levels in chronic Chagas disease patients

By  

PARASITE IMMUNOLOGY (ELECTRONIC), Vol. 37, Iss. 7, 2015-07 ,pp. : 376-379

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor‐α inhibition can stabilize disease in progressive vitiligo

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 641-650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor‐α inhibition can stabilize disease in progressive vitiligo

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 641-650

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vitro and in vivo release properties of brilliant blue and tumour necrosis factor-alpha (TNF-alpha) from poly(D,L-lacticco-glycolic acid) multiphase microspheres

By Iwata M.   Nakamura Y.   Mcginity J. W.  

Journal of Microencapsulation, Vol. 16, Iss. 6, 1999-11 ,pp. : 777-792

Informa Healthcare

Access to resources Recommend Favorite